Re: Saint-Laurent Thibault C, Moorjaney D, Ganz ML, et al. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. J Med Econ 2017;20:692-702. (2nd November 2017) - Patel, Jayeshkumar; Zhao, Xiaohui; Shah, Drishti; Alhussain, Khalid; Kamal, Khalid